// App-Quantinova.ai

: Patient demographics and clinical characteristics in the UK Salford Lung Study (SLS COPD) and the European ACCESS study

Researchers

Presenter

  • Maurice Driessen

Principal Investigators

  • Isabelle Boucot

  • Hana Mllerov

  • Dominy Browning

Medical Centers

  • Value Evidence and Outcomes, GSK, London, United Kingdom.

  • Global Respiratory Franchise, GSK, Brentford, Middlesex, United Kingdom,

  • Real World Evidence & Epidemiology, GSK, Stevenage, United Kingdom,

  • Research and Development, GSK, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • Catalase

Drug/Treatment

  • Fluticasone furoate

Outcome

  • N/A

Study Design

  • Randomized

  • Open Label

  • Non Interventional

  • Controlled

Phase

  • NA

Study Id's

  • NCT01551758

  • NCT01516528

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved